https://www.aiforpharma.org/ 2026-09-16T23:24:16+00:00 daily 1.0 https://www.aiforpharma.org/2026/09/11/making-generative-ai-fit-for-gmp-validation-must-move-beyond-determinism/ 2026-09-11T18:45:37+00:00 https://www.aiforpharma.org/2026/09/08/pmda-and-pics-put-draft-annex-22-at-the-centre-of-gmp-inspector-training/ 2026-09-08T19:59:56+00:00 https://www.aiforpharma.org/2026/09/08/uk-government-publishes-ai-risk-management-toolkit-%e2%80%93-a-practical-model-pharma-can-adapt-for-ai-governance/ 2026-09-08T19:55:31+00:00 https://www.aiforpharma.org/2026/09/02/ai-in-medicines-accuracy-and-reliability-emerge-as-the-top-regulatory-science-priorities/ 2026-09-02T17:37:08+00:00 https://www.aiforpharma.org/2026/08/31/fda-scientists-propose-%e2%80%9ccomputable-pharmacovigilance%e2%80%9d-automate-what-can-be-verified-keep-human-judgment-where-it-cannot/ 2026-08-31T17:25:33+00:00 https://www.aiforpharma.org/2026/08/28/pda-ai-in-quality-metrics-should-complement-%e2%80%93-not-replace-%e2%80%93-the-quality-system/ 2026-08-28T19:25:17+00:00 https://www.aiforpharma.org/2026/08/22/different-concepts-of-ai-control-in-gmp-and-pharma/ 2026-08-22T19:25:51+00:00 https://www.aiforpharma.org/2026/08/21/fda-experience-shows-model-based-pharmaceutical-manufacturing-is-already-regulatory-reality/ 2026-08-21T14:39:30+00:00 https://www.aiforpharma.org/2026/08/21/eu-ai-act-enforcement-has-started-what-the-2-august-2026-milestone-means-for-pharmaceutical-companies/ 2026-08-21T14:29:55+00:00 https://www.aiforpharma.org/2026/08/20/fda-proposes-a-new-way-to-evaluate-generative-ai-from-exhaustive-testing-to-competency-based-lifecycle-assurance/ 2026-08-20T19:13:59+00:00 https://www.aiforpharma.org/2026/08/07/new-mhra-backed-survey-pharma-is-exploring-ai-in-cmc-but-regulated-adoption-remains-limited/ 2026-08-07T15:42:30+00:00 https://www.aiforpharma.org/2026/07/15/mhra-sets-clear-expectations-for-ai-assisted-gxp-inspection-responses/ 2026-07-15T12:24:38+00:00 https://www.aiforpharma.org/2026/07/11/ema-annex-22-ai-workshop-awaiting-official-conclusions-but-the-direction-of-discussion-is-important/ 2026-07-11T18:15:14+00:00 https://www.aiforpharma.org/2026/07/10/digital-standards-and-machine-readable-compendial-methods-may-become-a-key-enabler-for-ai-in-qc-laboratories/ 2026-07-10T17:15:05+00:00 https://www.aiforpharma.org/2026/07/07/new-open-access-paper-proposes-an-integrated-validation-and-lifecycle-framework-for-ai-in-gxp-applications/ 2026-07-07T18:57:00+00:00 https://www.aiforpharma.org/2026/06/10/open-access-paper-llms-in-quality-management-with-a-risk-stratified-deployment-model-frontiers-2026/ 2026-06-10T16:35:44+00:00 https://www.aiforpharma.org/2026/06/10/ema-explains-how-its-ai-tool-%e2%80%9cscientific-explorer%e2%80%9d-is-validated-and-controlled-faq-updated-march-2026/ 2026-06-10T16:30:12+00:00 https://www.aiforpharma.org/2026/06/10/emahma-published-the-2025-ai-observatory-report-june-2026/ 2026-06-10T16:28:40+00:00 https://www.aiforpharma.org/2026/05/12/ema-workshop-planned-for-30-june-2026-on-expert-contributions-to-the-development-of-ai-annex-22/ 2026-05-12T19:13:11+00:00 https://www.aiforpharma.org/2026/04/25/isoiec-42001-the-ai-management-system-standard-aims-%e2%80%94-what-it-means-for-pharma/ 2026-04-25T17:47:17+00:00 https://www.aiforpharma.org/2026/04/25/fda-cgmp-enforcement-warning-letter-explicitly-calls-out-%e2%80%9cinappropriate-use-of-artificial-intelligence-in-pharmaceutical-manufacturing%e2%80%9d-apr-2026/ 2026-04-25T17:28:58+00:00 https://www.aiforpharma.org/2026/04/14/international-ai-safety-report-2026/ 2026-04-14T19:24:23+00:00 https://www.aiforpharma.org/2026/04/06/hmaema-has-published-the-network-data-steering-group-ndsg-workplan-2026%e2%80%932028-version-20-adopted-february-2026/ 2026-04-06T15:44:28+00:00 https://www.aiforpharma.org/2026/03/09/eu-regulators-formalize-industry-dialogue-on-ai-across-the-medicines-lifecycle-hma-ema-ai-group/ 2026-03-09T19:44:46+00:00 https://www.aiforpharma.org/2026/03/05/fda-deploys-internal-generative-ai-tooling-to-speed-scientific-reviews-%e2%80%9celsa%e2%80%9d-agency-wide-rollout/ 2026-03-05T19:44:48+00:00 https://www.aiforpharma.org/2026/02/05/key-ai-gmp-relevant-documents/ 2026-02-05T11:44:29+00:00 https://www.aiforpharma.org/2026/02/04/ema-and-fda-have-published-guiding-principles-of-good-ai-practice-in-drug-development/ 2026-02-04T16:57:05+00:00 https://www.aiforpharma.org/2026/01/27/what-is-artificial-intelligence-ai/ 2026-01-27T19:48:19+00:00 https://www.aiforpharma.org/?page=about 2026-01-26T16:29:33+00:00 https://www.aiforpharma.org/?page=check-your-email 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=invalid-email 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=invalid-token 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=legal-notice 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=menu 2026-01-26T16:29:33+00:00 https://www.aiforpharma.org/?page=privacy-policy 2026-01-26T16:29:33+00:00 https://www.aiforpharma.org/?page=static1777155839 2026-04-25T21:24:53+00:00 https://www.aiforpharma.org/?page=subscription-confirmed 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=throttle-limit 2011-11-11T10:11:11+00:00 https://www.aiforpharma.org/?page=unsubscribe-success 2011-11-11T10:11:11+00:00